Skip to main content

Table 1 Summary of results of virus production processes tested in various cell lines in iCELLis bioreactors (or predecessors).

From: Linear scalability of virus production in the integrity® iCELLis® single-use fixed-bed bioreactors from bench to industrial scale

Cells

Virus

Bioreactor

Surface Area (m2)

Average Cell Density at TOI (cells/cm2)

Specific Virus Productivity

Total Virus

CEF

Modified Vaccina Ankara

Artefix

0.07

3.9E+05

3.0E+06

pfu/cm2

2.1E+09

pfu

MDBK

Bovine Herpes Virus

iCELLis nano

4

1.2E+05

2.2E+07

pfu/cm2

8.7E+11

pfu

  

iCELLis pilot

20

1.4E+05

1.7E+07

pfu/cm2

3.4E+12

pfu

  

iCELLis 500

66

3.3E+05

3.3E+07

pfu/cm2

2.2E+13

pfu

A549

rAAV

iCeLLis nano

0.53

6.0E+04

5.3E+08

vg/cm2

2.8E+12

vg

 

Adenovirus

iCELLis nano

2.67

2.3E+05

1.1E+10

TCID50/cm2

3.0E+14

TCID50

Vero

Influenza

iCELLis nano

4

1.0E+05

3.8E+06

TCID50/cm2

1.5E+11

TCID50

  

iCELLis pilot

20

7.5E+04

2.5E+06

TCID50/cm2

5.0E+11

TCID50

 

Paramyxovirus

iCELLis nano

2.67

2.7E+05

6.4E+05

TCID50/cm2

1.7E+10

pfu

Vero

Undisclosed Lytic Virus

iCELLis pilot

40

1.5E+05

Confidential

Confidential

  

iCELLis 500

133

1.5E+05

    
  

iCELLis 1000

660

2.3E+05